ERASCA, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.89 USD | +2.16% |
|
-14.71% | -11.50% |
| 05-08 | Erasca, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-03 | North American Morning Briefing : Powell Awaited -2- | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 320M | - | - | - | - | - | |
| 44.96B | - | |||||
| 42.65B | ||||||
| 41.85B | ||||||
| 29.04B | ||||||
| 26.08B |
- Stock Market
- Equities
- ERAS Stock
- Charts Erasca, Inc.
- Sector Chart
